The European landscape has seen a unique evolution in the understanding of psychedelics. Recently stigmatized, these substances have begun to receive attention for their healing applications. From Germany, where clinical trials are underway, to the France, where open conversations is growing, Europe stands out in this re-evaluation of copyright cul